Ask a doctor about a prescription for RIXACAM 10 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Rixacam 10 mg film-coated tablets EFG
rivaroxaban
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rixacam contains the active ingredient rivaroxaban and is used in adults for:
Rixacam belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rixacam
Do not take Rixacam and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Be particularly careful with this medication
(bronchiectasis) or have had a previous bleeding in the lungs
Tell your doctor if you have any of these situationsbefore taking this medication. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
Children and adolescents
This medication is not recommended for children under 18 years of age.There is not enough information about its use in children and adolescents.
Other medications and Rixacam
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including those purchased without a prescription.
If any of the above circumstances apply to you, tell your doctorbefore taking this medication, as the effect of this medication may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they may recommend that you also use a preventive treatment for ulcers.
If any of the above circumstances apply to you, tell your doctorbefore taking this medication, as the effect of this medication may be reduced. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take this medication if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking this medication. If you become pregnant while taking this medication, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
This medication may cause dizziness (frequent side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rixacam contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow your doctor's instructions for taking this medication exactly. If you are in doubt, consult your doctor or pharmacist again.
What dose to take
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed rivaroxaban 10 mg once a day.
Swallow the tablet, preferably with water.
This medication can be taken with or without food.
If you have difficulty swallowing the whole tablet, consult your doctor about other ways to take this medication. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the crushed tablet of this medication through a gastric tube.
When to take Rixacam
Take one tablet every day, until your doctor tells you to stop.
Try to take one tablet at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet 6 to 10 hours after the operation.
If you have undergone major hip surgery, you will usually take tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take tablets for 2 weeks.
If you take more Rixacam than you should
Call your doctor immediately if you have taken too many tablets of this medication. Taking too much Rixacam increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or nurse immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rixacam
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rixacam
Do not stop taking this medication without talking to your doctor first, as this medication prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
Like other similar medications to reduce blood clot formation, this medication can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide whether to keep you under closer observation or change your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Rixacam
Tablet core: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, hypromellose, sodium lauryl sulfate, and magnesium stearate.
Tablet film coating: hypromellose, hydroxypropylcellulose, macrogol, titanium dioxide (E171), and red iron oxide (E172).
Appearance and package contents of the product
Rixacam 10 mg film-coated tablets are light pink, round, biconvex tablets, engraved with the number "10" on one side.
They are packaged in blisters, in packs of 10, 30, 98, or 100 film-coated tablets.
Only some pack sizes may be marketed.
Marketing authorization holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2nd floor
28023 Madrid
Spain
Manufacturer
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medicine is authorizedin the Member States of the European Economic Area under the following names:
Member State | Medicine name |
Poland | RIXACAM |
Czech Republic | RIXACAM |
Latvia | RIXACAM 10 mg film-coated tablets |
Slovakia | RIXACAM 10 mg |
Germany | RIXACAM 10 mg, film-coated tablets |
Denmark | RIXACAM |
Spain | Rixacam 10 mg film-coated tablets EFG |
Italy | RIXACAM |
Date of last revision of this leaflet:January 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for RIXACAM 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.